D-1082-2023 Class III Terminated
FDA drug recall D-1082-2023 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Jul 18, 2023 and is designated Class III. Reason for recall: Out of Specification result observed in content uniformity testing The recall status is terminated (terminated Feb 26, 2024). Affected quantity: 360 60-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 16, 2023
- Initiation Date
- Jul 18, 2023
- Termination Date
- Feb 26, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 360 60-count bottles
Product description
Dofetilide Capsules 500 mcg (0.5mg), 60-count bottle, Rx Only, Manufactured by Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T of D & NH), India, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512. NDC 47335-063-86
Reason for recall
Out of Specification result observed in content uniformity testing
Distribution pattern
Nationwide in the USA
Code information
Lot: DNE0217A, Exp 01/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1082-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026